Joseph H. Capper serves as the Chief Executive Officer at MIMEDX GROUP, INC., a leading biopharmaceutical company specializing in the development and commercialization of regenerative medicine products. With a robust background in the life sciences and healthcare sectors, Capper has been instrumental in steering MIMEDX towards significant growth and innovation. Prior to joining MIMEDX, he held several high-profile positions, including President and CEO of AngioDynamics, Inc., where he successfully led the company through a period of strategic transformation and market expansion. At MIMEDX, Capper has been pivotal in advancing the company's mission to improve patient outcomes through the use of placental-derived allografts and other biologics. Under his leadership, MIMEDX has expanded its product portfolio and strengthened its market position, particularly in the areas of wound care and surgical applications. His strategic vision has also driven the company to forge key partnerships and collaborations, enhancing its research and development capabilities. Capper's commitment to excellence and innovation has earned him recognition within the industry, and he continues to be a driving force behind MIMEDX's efforts to revolutionize regenerative medicine. In addition to his professional achievements, Joseph H. Capper is known for his dedication to corporate social responsibility and patient advocacy. He actively participates in industry conferences and events, sharing insights on the future of regenerative medicine and the importance of ethical business practices. His leadership style emphasizes transparency, collaboration, and a patient-first approach, which has fostered a strong corporate culture at MIMEDX. As CEO, Capper remains focused on advancing the company's goals while ensuring that MIMEDX continues to make a positive impact on the lives of patients worldwide.